TwinBeech Capital’s Haemonetics HAE Stock Holding History

TwinBeech Capital’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$205K	Buy	+3,633	New	+$237K	0.02%	513
2025 Q4	–	Sell	-16,804	Closed	-$819K	–	701
2025 Q3	$819K	Buy	+16,804	New	+$1.04M	0.03%	342
2024 Q4	–	Sell	-4,487	Closed	-$361K	–	738
2024 Q3	$361K	Buy	+4,487	New	+$362K	0.01%	606
2024 Q1	–	Sell	-41,396	Closed	-$3.54M	–	693
2023 Q4	$3.54M	Buy	+41,396	New	+$3.58M	0.06%	323
2023 Q3	–	Sell	-14,982	Closed	-$1.28M	–	743
2023 Q2	$1.28M	Buy	+14,982	New	+$1.27M	0.03%	429
2023 Q1	–	Sell	-65,972	Closed	-$5.19M	–	731
2022 Q4	$5.19M	Buy	+65,972	New	+$5.3M	0.1%	251
2022 Q1	–	Sell	-22,426	Closed	-$1.19M	–	599
2021 Q4	$1.19M	Buy	+22,426	New	+$1.37M	0.07%	314
2021 Q2	–	Sell	-8,350	Closed	-$927K	–	526
2021 Q1	$927K	Buy	8,350 +6,234	+295%	+$771K	0.14%	202
2020 Q4	$251K	Buy	+2,116	New	+$228K	0.04%	382
2020 Q1	–	Sell	-10,902	Closed	-$1.25M	–	367
2019 Q4	$1.25M	Buy	+10,902	New	+$1.32M	0.36%	88

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TwinBeech Capital's HAE Position: Q1 2026 in Review

TwinBeech Capital opened a new position in Haemonetics (HAE) in Q1 2026: 3,633 shares worth $205K. The stake represents 0.02% of the portfolio and ranks #513 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in HAE as recently as Q3 2025.

TwinBeech Capital first reported a position in HAE in Q4 2019 and has held it in 10 quarters since. The position peaked at $5.19M in Q4 2022. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

TwinBeech Capital held 3,633 shares of Haemonetics worth $205K as of Q1 2026.
Haemonetics was a new TwinBeech Capital position in Q1 2026.
Haemonetics made up 0.02% of TwinBeech Capital's portfolio in Q1 2026, its #513 holding.
TwinBeech Capital first reported a position in Haemonetics in Q4 2019 and has held it in 10 quarters since.
TwinBeech Capital's Haemonetics position peaked at $5.19M in Q4 2022.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.